Softwr

Healthcare · head to head

Aidoc vs Beckman Coulter DxONE

Aidoc logo

Aidoc

Healthcare

FDA cleared radiology AI for triage and notification of time critical findings

From
On request
Rated
-
Beckman Coulter DxONE logo

Beckman Coulter DxONE

Healthcare

Clinical laboratory middleware and informatics from a diagnostics instrument manufacturer

From
On request
Rated
-

The short version

  • Each has a real cost: Aidoc the clearances are for triage and notification in the CADt category, so the software may reorder a worklist but may not deliver a diagnosis or replace a read, and business cases built on reduced radiologist workload do not survive contact with the regulatory wording.; Beckman Coulter DxONE the rules and quality control workflows are tuned to Beckman analysers, so laboratories with a mixed Roche, Abbott and Siemens fleet get materially less coverage and typically buy vendor neutral middleware such as Data Innovations Instrument Manager instead.
  • They diverge on capability: Aidoc covers Triage and notification, Beckman Coulter DxONE covers DxONE Command Central.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Aidoc and Beckman Coulter DxONE actually diverge.

Attributes where Aidoc and Beckman Coulter DxONE differ
AttributeAidocBeckman Coulter DxONE
PlatformsWeb, iOS, AndroidWeb, Windows

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Aidoc

  • Triage and notification
  • Intracranial haemorrhage
  • Pulmonary embolism
  • Large vessel occlusion
  • Pneumothorax on X-ray
  • aiOS platform
  • Clinical workflow notifications

Only in Beckman Coulter DxONE

  • DxONE Command Central
  • DxONE Workflow Manager
  • REMISOL Advance
  • DxONE Inventory Manager
  • Autoverification rules
  • Quality control monitoring
  • LIS interfacing

What people use each for

The jobs each tool is most often brought in to do.

Aidoc

  • A regional stroke centre that wants large vessel occlusion flagged and the neurointervention team notified before the radiologist dictatesnot Beckman Coulter DxONE
  • A trauma centre wanting cervical spine fracture and intra abdominal free gas prioritised in an overnight queue read by one on call radiologistnot Beckman Coulter DxONE
  • An oncology imaging programme that wants incidental pulmonary embolism caught on staging CTs ordered for a different questionnot Beckman Coulter DxONE
  • A health system that has bought AI from several vendors and wants one PACS integration through aiOS rather than one integration per algorithmnot Beckman Coulter DxONE

Beckman Coulter DxONE

  • A hospital laboratory standardising on Beckman DxC and DxI analysers that wants autoverification to release the majority of routine chemistry without technologist reviewnot Aidoc
  • A low volume rural laboratory that cannot justify on premises middleware servers and needs a cloud hosted rules enginenot Aidoc
  • A multi site laboratory network that needs identical autoverification rules applied consistently across every site, which REMISOL Advance is built fornot Aidoc
  • A laboratory whose LIS cannot express delta checks or repeat rules and needs that logic to live in middleware insteadnot Aidoc

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Aidoc

  • The clearances are for triage and notification in the CADt category, so the software may reorder a worklist but may not deliver a diagnosis or replace a read, and business cases built on reduced radiologist workload do not survive contact with the regulatory wording.
  • Triage algorithms are tuned for sensitivity, so false positives are routine, and each one interrupts a radiologist. Sites that do not measure positive predictive value in their own case mix see clinician trust erode within months.
  • Pricing is per algorithm and per study volume with no published rate card, so the cost of a multi algorithm deployment escalates sharply and cannot be benchmarked before a sales conversation.
  • The clinical benefit accrues to stroke, trauma and cardiology service lines while the cost usually lands in the radiology or IT budget, which makes internal funding harder than the return on investment slides suggest.
  • Performance depends on scanner protocols and reconstruction settings, so results validated at one site do not transfer, and each deployment needs local validation work that is rarely budgeted for.

Beckman Coulter DxONE

  • The rules and quality control workflows are tuned to Beckman analysers, so laboratories with a mixed Roche, Abbott and Siemens fleet get materially less coverage and typically buy vendor neutral middleware such as Data Innovations Instrument Manager instead.
  • Pricing is bundled into analyser and reagent contracts rather than itemised, so a laboratory cannot compare the informatics cost against a standalone middleware quote and often does not know what it is paying for the software.
  • Because the software is tied to a reagent rental term, the real cost of switching middleware is the remaining years of the reagent commitment, not a software renewal, which locks the laboratory in far longer than a software contract would.
  • DxONE Workflow Manager and REMISOL Advance are different products with different rule engines rather than one product at two sizes, so a laboratory that grows out of Workflow Manager faces a migration and rule rewrite, not an upgrade.
  • Interface builds to the hospital LIS are professional services work quoted per interface, and laboratories consistently underestimate this line, particularly where the LIS is an older Sunquest or SCC installation.

Pricing, plan by plan

Aidoc

On request
  • Aidoc$undefined/year
    • Annual subscription priced by algorithm and by study volume
    • aiOS platform integration licensed separately from individual algorithms
    • Multi algorithm bundles negotiated for enterprise deployments

Beckman Coulter DxONE

On request
  • DxONE$undefined/year
    • Quoted as part of an analyser or reagent contract, not as standalone software
    • Priced against instrument fleet size and test volume
    • Multi year reagent rental agreements are the usual commercial vehicle

Which should you pick?

Choose Aidoc if

  • You need triage and notification.
  • You work on Web, iOS, Android.
  • You also want intracranial haemorrhage.

Choose Beckman Coulter DxONE if

  • You need dxone command central.
  • You work on Web, Windows.
  • You also want dxone workflow manager.

Questions people ask

Is Aidoc or Beckman Coulter DxONE better?
Neither clearly leads. Aidoc starts at On request and Beckman Coulter DxONE at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Aidoc or Beckman Coulter DxONE?
Aidoc starts at On request and Beckman Coulter DxONE at On request.
Does Aidoc or Beckman Coulter DxONE run on more platforms?
Aidoc runs on Web, iOS, Android. Beckman Coulter DxONE runs on Web, Windows.
What is Aidoc best used for?
Aidoc is most often used for a regional stroke centre that wants large vessel occlusion flagged and the neurointervention team notified before the radiologist dictates, a trauma centre wanting cervical spine fracture and intra abdominal free gas prioritised in an overnight queue read by one on call radiologist, an oncology imaging programme that wants incidental pulmonary embolism caught on staging cts ordered for a different question, a health system that has bought ai from several vendors and wants one pacs integration through aios rather than one integration per algorithm. Of those, a regional stroke centre that wants large vessel occlusion flagged and the neurointervention team notified before the radiologist dictates and a trauma centre wanting cervical spine fracture and intra abdominal free gas prioritised in an overnight queue read by one on call radiologist are not what Beckman Coulter DxONE is typically brought in for.
What can Aidoc do that Beckman Coulter DxONE cannot?
Aidoc covers Triage and notification, Intracranial haemorrhage, Pulmonary embolism, Large vessel occlusion. Beckman Coulter DxONE covers DxONE Command Central, DxONE Workflow Manager, REMISOL Advance, DxONE Inventory Manager.

Answered from the vendors’ own pages

Aidoc: Is Aidoc FDA cleared?

Yes, it holds multiple 510(k) clearances, but they are for computer aided triage and notification. It may prioritise a worklist and notify a team. It may not provide a diagnostic interpretation or replace a radiologist read.

Beckman Coulter DxONE: Can I buy DxONE without buying Beckman analysers?

Not realistically. It is quoted as part of an instrument or reagent agreement and its value is in the depth of integration with Beckman platforms. A laboratory with other analysers should look at vendor neutral middleware.

Aidoc: Does it reduce radiologist workload?

No. Every study still needs a full read. The benefit is in the order studies are read and how quickly a receiving specialty is activated, not in reading fewer studies.

Beckman Coulter DxONE: Is DxONE the same as REMISOL Advance?

No. REMISOL Advance is the on premises middleware for higher volume and multi site laboratories. DxONE Workflow Manager is a separate cloud product aimed at low volume laboratories. They are not the same rule engine.

Aidoc: Can I run other vendors AI through it?

Yes, that is what the aiOS platform layer is for, and for health systems with several AI vendors it is often the main reason to buy Aidoc at all.

Beckman Coulter DxONE: Does Beckman publish pricing?

No. Everything is quoted, and the software cost is usually folded into a cost per reportable result on a reagent contract rather than shown as a licence fee.

Aidoc: Is pricing published?

No. It is quoted per algorithm and by annual study volume, and enterprise bundles are negotiated case by case.

Beckman Coulter DxONE: Is DxONE a regulated medical device?

The middleware components carry regulatory registrations that vary by product and region. Autoverification of diagnostic results is a regulated function, so confirm the specific clearance for the module and country before deployment.

Share

Related pages

Other head to heads